Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Biotech
BMS pays Leqembi originator $100M for Alzheimer's prospects
Bristol Myers has turned to the source of Leqembi to push into Alzheimer’s, paying BioArctic $100 million upfront for two preclinical antibodies.
Nick Paul Taylor
Dec 19, 2024 5:23am
Bristol Myers culls cell therapy deals with 2 biotechs
Dec 16, 2024 11:19am
Nuvig raises $161M with 4 Big Pharmas in tow
Dec 5, 2024 7:00am
BMS taps AI Proteins in drug discovery collab worth up to $400M
Dec 3, 2024 10:45am
NJ biopharmas make pledge to give time off for clinical trials
Nov 20, 2024 10:00am
J&J, Protagonist's oral psoriasis prospect scores in phase 3s
Nov 19, 2024 11:44am
